Our mission is to triple the pancreatic cancer survival rate by 2030 and dramatically improve the quality of life for those impacted by the disease.
PanKind, The Australian Pancreatic Cancer Foundation, is exclusively dedicated to improving outcomes for Australians impacted by pancreatic cancer.
We are achieving results through a strategic investment in groundbreaking medical research and critically, PanKind is often the first to provide funding for these projects. We are the lead funder, identifying the potential for patients and providing the initial investment to enable projects to grow bigger and have a greater impact.
Early-stage pancreatic cancer rarely causes signs or symptoms, which can make it difficult to diagnose, that is why we are working towards a breakthrough in early detection. We also support patients and carers through information and resources, and advocating for better patient outcomes.
We invite you to join us on the journey to improve survival rates and the quality of life for the thousands of Australians affected by this disease every year.
Take Action Our Approach
Achievements
Latest news
PBAC reviews new treatment
Your opinion is required to help the Pharmaceutical Benefits Advisory Committee (PBAC) evaluate whether a new treatment should be funded for metastatic pancreatic cancer.
Read story ➞PanKind - 2023 Year in Numbers
Impact in Research 2023
Celebrating life through art
Your support matters. Keep in Touch.
Sign up to keep up-to-date with the latest news, upcoming events, personal stories and exciting breakthroughs, sent to your email.